C12N2500/16

METHODS FOR PRODUCING RECOMBINANT PROTEINS
20200207812 · 2020-07-02 · ·

Provided herein are methods of producing a recombinant protein that include: providing a bacterium including a nucleic acid encoding a recombinant protein; and culturing the bacterium in a liquid culture medium including about 0.3 mM to about 300 mM Mg.sup.2+ under conditions sufficient for the production and release of the recombinant protein into the culture medium.

MEDIA FOR MICROORGANISM CULTURE AND RELATED COMPOSITIONS AND METHODS

Disclosed is media for cultivating cells, e.g., Pichia Pastoris cells, as well as cultures containing cells, methods for making and using the media, and kits comprising the media. The media is particularly useful in the context of therapeutic protein production.

METHOD FOR PREPARATION OF FUNGAL MUTANT WITH HIGH HYDROLYTIC ACTIVITY

A method for preparing a hyper-cellulolytic catabolite derepressed mutants of ascomycetes fungus, especially variants of Penicillium funiculosum. Selection media used to isolate such variants include amorphous cellulose and a high concentration of glucose. Cellulase activities of mutant ID-10, in particular such as FPase and -glucosidase were 1.5 times higher than Penicillium funiculosum MRJ-16 (parent). Furthermore, fungal mutant morphology was changed and no pH adjustment was required throughout the enzyme production process.

Bacterial Growth on Non-Animal Derived Media
20200181565 · 2020-06-11 · ·

The invention is directed to tools, compositions, and methods for the cultivation of microorganisms in culture media that is devoid of animal-derived materials such as blood, and, in particular, to compositions of meat-free media.

Preparation of small colony variants of therapeutic bacteria

The invention relates to methods of differentiation, isolation, propagation, and storage of small colony variants (SCVs) of E. coli, preferably E. coli 83972 or E. coli HU2117, or modified or variant forms thereof, and methods for using the prepared SCV bacteria to establish probiotic biofilms in treated subjects and/or on treated medical devices.

COMPOSITION AND METHOD FOR CONTROLLING INSECTS AND MICROORGANISMS USING PSEUDOMONAS TAIWANENSIS
20200123495 · 2020-04-23 ·

Described herein are methods and compositions for controlling insects and microorganims growth using Pseudomonas taiwanensis and its culture broth.

SOLID MEDIUM FOR PRODUCING GLUCOSAMINE AND ITS APPLICATION
20200087693 · 2020-03-19 ·

The invention relates to solid medium for producing glucosamine, including a substrate and 0.15-4.8 mL/g substrate of supplemental solution, which includes 0.1-2 g/L KH.sub.2PO.sub.4, 0.1-2 g/L NaCl, and 0.1-2 g/L MgSO.sub.4.7H.sub.2O. The invention also relates to a method for producing glucosamine, including providing microorganism being able to produce glucosamine, and fermenting the microorganism in the medium mentioned above.

Method of reseeding adherent cells grown in a hollow fiber bioreactor system

This invention is directed to methods of directly reseeding harvested adherent cells grown in a hollow fiber bioreactor. Also disclosed is a novel harvest media for use in directly reseeding adherent cells into a hollow fiber bioreactor.

CELL CULTURE MEDIA
20200040301 · 2020-02-06 ·

A cell culture medium comprising adenosine triphosphate; a carrier protein; cholesterol, linoleic acid, and lipoic acid; glutathione; at least one nucleotide salvage pathway precursor base; phosphoethanolamine; selenium; transferrin; triiodothyronine; all-trans-retinoic acid (ATRA) and vitamin C; zinc, magnesium, and copper; an agent that increases intracellular cAMP; epidermal growth factor (EGF); hydrocortisone; insulin; and charcoal stripped fetal bovine serum, wherein said cell culture medium is substantially free, if not entirely free, of vitamin D, androgenic hormones, androgenic ligands, estrogenic hormones, estrogenic ligands, and/or androgenic receptors.

COMPOSITIONS AND METHODS FOR IMPROVING MITOCHONDRIAL FUNCTION

Provided herein are methods and compositions comprising a bacterium or a metabolite thereof for enhancing mitochondrial and/or peroxisomal function.